Renal function and attributable risk of death and cardiovascular hospitalization in participants with diabetes from a registry-based cohort


      • A eGFR < 90 mL/min/1.73 m2 was associated with increased mortality risk (p < 0.001).
      • A eGFR < 90 mL/min/1.73 m2 was associated with increased hospitalizations (p < 0.001).
      • Mortality estimated PAR associated with eGFR levels < 60 was significant in DM.
      • Mortality estimated PAR associated with eGFR levels < 60 was significant in CVD.



      To estimate the attributable risk of renal function on all-cause mortality and cardiovascular hospitalization in patients with diabetes.


      A prospective cohort study in 19,469 adults with diabetes, free of cardiovascular disease, attending primary care in Spain (2008–2011). The estimated glomerular filtration rate (eGFR) and other variables were collected and patients were followed to the first hospitalization for coronary or stroke event, or death, until the end of 2012. The cumulative incidence of the study endpoints by eGFR categories was graphically displayed and adjusted population attributable risks (PARs) for low eGFR was calculated.


      Mean follow-up was 3.2 years and 506 deaths and 1720 hospitalizations were recorded. The cumulative risk for the individual events increased as eGFR levels decreased. The PAR associated with having an eGFR of 60 mL/min/1.73 m2 or less was 11.4% (95% CI 4.8–18.3) for all-cause mortality, 9.2% (95% CI 5.3–13.4) for coronary heart disease, and 2.6% (95% CI −1.8 to 7.4) for stroke.


      Reduced eGFR levels were associated with a larger proportion of avoidable deaths and cardiovascular hospitalizations in people with diabetes compared to previously reported results in people with other cardiovascular risk factors.



      CKD (chronic kidney disease), GFR (glomerular filtration rate), ACR (albumin-to-creatinine ratio), CVD (cardiovascular disease), CVR (cardiovascular risk), CV (cardiovascular), DM (diabetes mellitus), eGFR (estimated glomerular filtration rate), K/DOQI (Kidney Disease Outcome Quality Initiative), NHANES (National Health and Nutrition Examination Survey), BMI (body mass index), HER (electronic health record), CKD-EPI (chronic kidney disease epidemiology collaboration), STROBE (strengthening the reporting of observational studies in epidemiology), HDL (high density-lipoprotein), LDL (low-density lipoprotein), IDMS (isotope dilution mass spectrometry), CHD (coronary heart disease), ICD (International Classification of Diseases), CIOMS (Council for International Organizations of Medical Sciences), DGSP-CSISP (Committee for Ethics and Clinical Trials of the Center for Public Health Research), PARs (population attributable risks), CI (confidence interval), RR (related relative risks)
      To read this article in full you will need to make a payment


      Subscribe to Primary Care Diabetes
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Jager K.J.
        • Fraser S.D.S.
        The ascending rank of chronic kidney disease in the global burden of disease study.
        Nephrol. Dial. Transplant. 2017; 32: ii121-ii128
        • Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group
        KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.
        Kidney Int. Suppl. 2013; 3 ([Available online]): 1-150
        • Levey A.S.
        • Inker L.A.
        • Coresh J.
        GFR estimation: from physiology to public health.
        Am. J. Kidney Dis. 2014; 63: 820-834
        • Mahmoodi B.K.
        • Matsushita K.
        • Woodward M.
        • et al.
        Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a metaanalysis.
        Lancet. 2012; 380: 1649-1661
        • Fox C.S.
        • Matsushita M.
        • Woodward M.
        • et al.
        Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis.
        Lancet. 2012; 380: 1662-1673
        • Rodriguez-Poncelas A.
        • Miravet-Jiménez S.
        • Casellas A.
        • et al.
        Prevalence of diabetic retinopathy in individuals with type 2 diabetes who had recorded diabetic retinopathy from retinal photographs in Catalonia (Spain).
        Br. J. Ophthalmol. 2015; 99: 1628-1633
        • National Kidney Foundation
        K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.
        Am. J. Kidney Dis. 2002; 39: S1-S266
        • Coresh J.
        • Selvin E.
        • Stevens L.A.
        • et al.
        Prevalence of chronic kidney disease in the United States.
        JAMA. 2007; 298: 2038-2047
        • Thomas C.C.
        • Philipson L.H.
        Update on diabetes classification.
        Med. Clin. North Am. 2015; 99: 1-16
        • Afkarian M.
        • Sachs M.C.
        • Kestenbaum B.
        • et al.
        Kidney disease and increased mortality risk in type 2 diabetes.
        J. Am. Soc. Nephrol. 2013; 24: 208-302
        • Di Angelantonio E.
        • Danesh J.
        • Eiriksdottir G.
        • et al.
        Renal function and risk of coronary heart disease in general populations: new prospective study and systematic review.
        PLoS Med. 2007; 4: e270
        • Chronic Kidney Disease Prognosis Consortium
        • Matsushita K.
        • van der Velde M.
        • et al.
        Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.
        Lancet. 2010; 375: 2073-2081
        • Tellez-Plaza M.
        • Orozco-Beltran D.
        • Gil-Guillen V.
        • et al.
        Renal function and attributable risk of death and cardiovascular hospitalization in patients with cardiovascular risk factors from a registry-based cohort: the Estudio Cardiovascular Valencia-risk study.
        J. Hypertens. 2016; 34: 2266-2273
        • Cowie M.R.
        • Blomster J.I.
        • Curtis L.H.
        • et al.
        Electronic health records to facilitate clinical research.
        Clin. Res. Cardiol. 2017; 106: 1-9
        • Weinger M.B.
        Electronic health records.
        N. Engl. J. Med. 2010; 363: 2372-2374
        • Young J.
        • Eley D.
        • Fahey P.
        • et al.
        Enabling research in general practice: increasing functionality of electronic medical records.
        Aust. Fam. Physician. 2010; 39: 506-509
        • Gil-Guillen V.
        • Orozco-Beltran D.
        • Redon J.
        • et al.
        Rationale and methods of the cardiometabolic Valencian study (Escarval-Risk) for validation of risk scales in Mediterranean patients with hypertension, diabetes or dyslipidemia.
        BMC Public Health. 2010; 10: 717
        • Levey A.S.
        • Stevens L.A.
        • Schmid C.H.
        • et al.
        A new equation to estimate glomerular filtration rate.
        Ann. Intern Med. 2009; 150: 604-612
        • Rule A.D.
        • Larson T.S.
        • Bergstralh E.J.
        • et al.
        Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease.
        Ann. Intern. Med. 2004; 141: 929-937
        • Benichou J.
        A review of adjusted estimators of attributable risk.
        Stat. Methods Med. Res. 2001; 10: 195-216
        • Bruzzi P.
        • Green S.B.
        • Byar D.P.
        • et al.
        Estimating the population attributable risk for multiple risk factors using case-control data.
        Am. J. Epidemiol. 1985; 122: 904-914
        • Tomino Y.
        Pathogenesis and treatment of chronic kidney disease: a review of four recent basic and clinical data.
        Kidney Blood Press Res. 2014; 39: 450-489
        • Sarnak M.J.
        • Levey A.S.
        • Schoolwerth A.C.
        • et al.
        Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention.
        Circulation. 2003; 108: 2154-2169
        • Go A.S.
        • Chertow G.M.
        • Fan D.
        • et al.
        Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.
        N. Engl. J. Med. 2004; 35: 1296-1306
        • Selvin E.
        • Parrinello C.M.
        • Sacks D.B.
        • et al.
        Trends in prevalence and control of diabetes in the United States, 1988–1994 and 1999–2010.
        Ann. Intern. Med. 2014; 160: 517-525
        • Zelnick L.R.
        • Weiss N.S.
        • Kestenbaum B.R.
        • et al.
        Diabetes and CKD in the United States Population, 2009–2014.
        Clin. J. Am. Soc. Nephrol. 2017; 12: 1984-1990
        • Kramer H.
        • Boucher R.E.
        • Leehey D.
        • et al.
        Increasing mortality in adults with diabetes and low estimated glomerular filtration rate in the absence of albuminuria.
        Diabetes Care. 2018; (Pii dc171954)
        • Hsieh Y.-T.
        • Kuo J.-F.
        • Su S.-L.
        • et al.
        Subnormal estimated glomerular filtration rate strongly predict incident cardiovascular events in type 2 diabetic Chinese population with normoalbuminuria.
        Medicine. 2016; 95
        • Knobler H.
        • Zornitzki T.
        • Vered S.
        • et al.
        Reduced glomerular filtration rate in asymptomatic diabetic patients: predictor of increased risk for cardiac events independent of albuminuria.
        J. Am. Coll. Cardiol. 2004; 44: 2142-2148
        • Orozco-Beltran D.
        • Cooper R.S.
        • Gil-Guillen V.
        • et al.
        Trends in mortality from myocardial infarction. A comparative study between Spain and the United States: 1990–2006.
        Rev. Esp. Cardiol. (Engl. Ed.). 2012; 65: 1079-1085
        • Nichols M.
        • Townsend N.
        • Scarborough P.
        • et al.
        Cardiovascular disease in Europe: epidemiological update.
        Eur. Heart J. 2013; 34: 3028-3034